Results 171 to 180 of about 534,292 (302)

Computational Approaches and Observer Variation in the 3D Musculoskeletal Modeling of the Heads of Anolis. [PDF]

open access: yesIntegr Org Biol
Lagorio AD   +10 more
europepmc   +1 more source

Evaluation of inter-observer variation for computed tomography identification of childhood interstitial lung disease. [PDF]

open access: yesERJ Open Res, 2019
Jacob J   +18 more
europepmc   +1 more source

Transcriptional network analysis of PTEN‐protein‐deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communication

open access: yesMolecular Oncology, EarlyView.
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice   +16 more
wiley   +1 more source

Inter-observer variation in gross tumour volume delineation of oesophageal cancer on MR, CT and PET/CT. [PDF]

open access: yesRadiol Oncol
Secerov-Ermenc A   +6 more
europepmc   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

open access: yesMolecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak   +4 more
wiley   +1 more source

Artificial intelligence-generated targets and inter-observer variation in online adaptive radiotherapy of bladder cancer. [PDF]

open access: yesPhys Imaging Radiat Oncol
Åström LM   +8 more
europepmc   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

Gleason’s Grading of Prostatic Adenocarcinoma: Inter-Observer Variation Among Seven Pathologists at a Tertiary Care Center in Oman [PDF]

open access: yesAsian Pac J Cancer Prev, 2016
Qureshi A   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy